STOCK TITAN

Liquidia Corporation To Present At The Jefferies Virtual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Liquidia Corporation (NASDAQ: LQDA) announced that CEO Damian deGoa will present at the Jefferies Virtual Healthcare Conference on June 2, 2021, from 2:30 to 2:55 p.m. EDT. The session aims to provide an overview and update on the company's business strategies and developments. Investors and interested parties can access the live webcast through the Liquidia website, and an archived version will be available for 90 days post-event. Liquidia is focused on developing treatments for pulmonary hypertension using its proprietary PRINT® Technology.

Positive
  • None.
Negative
  • None.

MORRISVILLE, N.C., May 26, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that Mr. Damian deGoa, Chief Executive Officer of Liquidia, will provide an overview and update on the company's business during a fireside chat session at the Jefferies Virtual Healthcare Conference.

The presentation will take place on Wednesday, June 2, 2021, from 2:30 to 2:55 p.m. Eastern Daylight Time and can be accessed via a live webcast on the Liquidia website at https://liquidia.com/investors/events-and-presentations. An archived, recorded version of the presentation can be accessed for 90 days following the event.

About Liquidia Corporation
Liquidia Corporation is a biopharmaceutical company focused on the development and commercialization of products in pulmonary hypertension and other applications of its PRINT® Technology. The company operates through its two wholly owned subsidiaries, Liquidia Technologies, Inc. and Liquidia PAH, LLC. Liquidia Technologies is developing LIQ861, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH). Liquidia PAH provides the commercialization for rare disease pharmaceutical products, such as generic Treprostinil Injection. For more information, please visit www.liquidia.com.

Contact Information

Media & Investors:
Jason Adair
Vice President, Corporate Development and Strategy
919.328.4400
jason.adair@liquidia.com


FAQ

When will Liquidia Corporation present at the Jefferies Virtual Healthcare Conference?

Liquidia Corporation will present on June 2, 2021, from 2:30 to 2:55 p.m. EDT.

Who is providing the update for Liquidia Corporation at the conference?

CEO Damian deGoa will provide the update during the conference.

How can I access the Liquidia Corporation presentation at the conference?

You can access the presentation via a live webcast on the Liquidia website.

Will there be an archived version of Liquidia Corporation's presentation available?

Yes, an archived version will be available for 90 days after the event.

What is the focus of Liquidia Corporation's business?

Liquidia Corporation focuses on developing treatments for pulmonary hypertension using its PRINT® Technology.

Liquidia Corporation

NASDAQ:LQDA

LQDA Rankings

LQDA Latest News

LQDA Stock Data

912.38M
60.46M
19.49%
54.31%
12.25%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
MORRISVILLE